| pubmed-article:18650157 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:18650157 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:18650157 | lifeskim:mentions | umls-concept:C0278488 | lld:lifeskim |
| pubmed-article:18650157 | lifeskim:mentions | umls-concept:C0332174 | lld:lifeskim |
| pubmed-article:18650157 | lifeskim:mentions | umls-concept:C0078257 | lld:lifeskim |
| pubmed-article:18650157 | lifeskim:mentions | umls-concept:C0728747 | lld:lifeskim |
| pubmed-article:18650157 | lifeskim:mentions | umls-concept:C0282460 | lld:lifeskim |
| pubmed-article:18650157 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:18650157 | pubmed:dateCreated | 2008-7-24 | lld:pubmed |
| pubmed-article:18650157 | pubmed:abstractText | Trastuzumab combined with cytotoxic agents presents encouraging results in metastatic breast cancer (MBC), but cardiac toxicity limits some combinations. The synergism shown with trastuzumab and the favorable tolerability profile of vinorelbine provided the rationale for investigating this combination. | lld:pubmed |
| pubmed-article:18650157 | pubmed:language | eng | lld:pubmed |
| pubmed-article:18650157 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18650157 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:18650157 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18650157 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18650157 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18650157 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18650157 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18650157 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18650157 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18650157 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:18650157 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:18650157 | pubmed:issn | 1526-8209 | lld:pubmed |
| pubmed-article:18650157 | pubmed:author | pubmed-author:CrespoCarmenC | lld:pubmed |
| pubmed-article:18650157 | pubmed:author | pubmed-author:MayordomoJosé... | lld:pubmed |
| pubmed-article:18650157 | pubmed:author | pubmed-author:Sánchez-Rovir... | lld:pubmed |
| pubmed-article:18650157 | pubmed:author | pubmed-author:Gómez-BernalA... | lld:pubmed |
| pubmed-article:18650157 | pubmed:author | pubmed-author:García-Palomo... | lld:pubmed |
| pubmed-article:18650157 | pubmed:author | pubmed-author:Pérez-Carrión... | lld:pubmed |
| pubmed-article:18650157 | pubmed:author | pubmed-author:González-Flor... | lld:pubmed |
| pubmed-article:18650157 | pubmed:author | pubmed-author:Ruiz-BorregoM... | lld:pubmed |
| pubmed-article:18650157 | pubmed:author | pubmed-author:de la... | lld:pubmed |
| pubmed-article:18650157 | pubmed:author | pubmed-author:Bayo-CaleroJu... | lld:pubmed |
| pubmed-article:18650157 | pubmed:author | pubmed-author:IllaramendiJo... | lld:pubmed |
| pubmed-article:18650157 | pubmed:author | pubmed-author:García-BuenoJ... | lld:pubmed |
| pubmed-article:18650157 | pubmed:author | pubmed-author:Ramos-Vázquez... | lld:pubmed |
| pubmed-article:18650157 | pubmed:author | pubmed-author:Yubero-Esteba... | lld:pubmed |
| pubmed-article:18650157 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:18650157 | pubmed:volume | 8 | lld:pubmed |
| pubmed-article:18650157 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:18650157 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:18650157 | pubmed:pagination | 264-8 | lld:pubmed |
| pubmed-article:18650157 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
| pubmed-article:18650157 | pubmed:meshHeading | pubmed-meshheading:18650157... | lld:pubmed |
| pubmed-article:18650157 | pubmed:meshHeading | pubmed-meshheading:18650157... | lld:pubmed |
| pubmed-article:18650157 | pubmed:meshHeading | pubmed-meshheading:18650157... | lld:pubmed |
| pubmed-article:18650157 | pubmed:meshHeading | pubmed-meshheading:18650157... | lld:pubmed |
| pubmed-article:18650157 | pubmed:meshHeading | pubmed-meshheading:18650157... | lld:pubmed |
| pubmed-article:18650157 | pubmed:meshHeading | pubmed-meshheading:18650157... | lld:pubmed |
| pubmed-article:18650157 | pubmed:meshHeading | pubmed-meshheading:18650157... | lld:pubmed |
| pubmed-article:18650157 | pubmed:meshHeading | pubmed-meshheading:18650157... | lld:pubmed |
| pubmed-article:18650157 | pubmed:meshHeading | pubmed-meshheading:18650157... | lld:pubmed |
| pubmed-article:18650157 | pubmed:meshHeading | pubmed-meshheading:18650157... | lld:pubmed |
| pubmed-article:18650157 | pubmed:meshHeading | pubmed-meshheading:18650157... | lld:pubmed |
| pubmed-article:18650157 | pubmed:meshHeading | pubmed-meshheading:18650157... | lld:pubmed |
| pubmed-article:18650157 | pubmed:meshHeading | pubmed-meshheading:18650157... | lld:pubmed |
| pubmed-article:18650157 | pubmed:year | 2008 | lld:pubmed |
| pubmed-article:18650157 | pubmed:articleTitle | A phase II study of weekly vinorelbine and trastuzumab in patients with HER2-positive metastatic breast cancer. | lld:pubmed |
| pubmed-article:18650157 | pubmed:affiliation | Servicio de Oncología Médica, Hospital Juan Ramón Jiménez, Huelva, Spain. juanbayo@yahoo.es | lld:pubmed |
| pubmed-article:18650157 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:18650157 | pubmed:publicationType | Clinical Trial, Phase II | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18650157 | lld:pubmed |
